Clinical Trial Update: Evaluation of Metformin, Targeting Cancer Stem Cells for Prevention of Relapse in Gynecologic Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating metformin for preventing relapse by targeting cancer stem cells in gynecologic cancers; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Ovarian, Fallopian Tube, and Primary Peritoneal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-05-25